These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge. Zaiss AK; Muruve DA Gene Ther; 2008 Jun; 15(11):808-16. PubMed ID: 18385765 [TBL] [Abstract][Full Text] [Related]
3. How not to be seen: immune-evasion strategies in gene therapy. Zaldumbide A; Hoeben RC Gene Ther; 2008 Feb; 15(4):239-46. PubMed ID: 18046427 [TBL] [Abstract][Full Text] [Related]
4. Challenges of immune responses in gene replacement therapy. Ertl HC IDrugs; 2005 Sep; 8(9):736-8. PubMed ID: 16118696 [TBL] [Abstract][Full Text] [Related]
7. Immune responses to gene therapy vectors: influence on vector function and effector mechanisms. Bessis N; GarciaCozar FJ; Boissier MC Gene Ther; 2004 Oct; 11 Suppl 1():S10-7. PubMed ID: 15454952 [TBL] [Abstract][Full Text] [Related]
8. Challenges and strategies: the immune responses in gene therapy. Zhou HS; Liu DP; Liang CC Med Res Rev; 2004 Nov; 24(6):748-61. PubMed ID: 15250039 [TBL] [Abstract][Full Text] [Related]
12. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection. Douglas KL Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953 [TBL] [Abstract][Full Text] [Related]
13. Innate and adaptive immune pathways to tolerance. Thornton CA; Morgan G Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514 [TBL] [Abstract][Full Text] [Related]
14. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers. Sinkovics JG; Horvath JC Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757 [TBL] [Abstract][Full Text] [Related]